US Bancorp
GALT icon

US Bancorp’s Galectin Therapeutics GALT Stock Holding History

US Bancorp’s Portfolio GALT Stock Details GALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-118,921
Closed -$397K – 3628
2017
Q4 		$397K Hold
118,921
– – ﹤0.01% 1541
2017
Q3 		$254K Hold
118,921
– – ﹤0.01% 1747
2017
Q2 		$293K Hold
118,921
– – ﹤0.01% 1643
2017
Q1 		$274K Buy
118,921
+28,087
+31% +$42.3K ﹤0.01% 1661
2016
Q4 		$89K Hold
90,834
– – ﹤0.01% 2171
2016
Q3 		$103K Hold
90,834
– – ﹤0.01% 2063
2016
Q2 		$134K Hold
90,834
– – ﹤0.01% 1869
2016
Q1 		$130K Hold
90,834
– – ﹤0.01% 1881
2015
Q4 		$149K Hold
90,834
– – ﹤0.01% 1841
2015
Q3 		$213K Hold
90,834
– – ﹤0.01% 1703
2015
Q2 		$248K Buy
+90,834
New +$274K ﹤0.01% 1671

Other funds holding GALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return
BCA
Benchmark Capital Advisors New York $100M AUM 0.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.06B AUM 20.01% 1-Year Est. Return